Everence Capital Management’s Dentsply Sirona XRAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-18,382
| Closed | -$213K | – | 940 |
|
|
2026
Q1 | $213K | Buy |
+18,382
| New | +$229K | 0.01% | 727 |
|
|
2025
Q4 | – | Sell |
-12,220
| Closed | -$155K | – | 842 |
|
|
2025
Q3 | $155K | Hold |
12,220
| – | – | 0.01% | 787 |
|
|
2025
Q2 | $194K | Sell |
12,220
-5,790
| -32% | -$86.6K | 0.01% | 760 |
|
|
2025
Q1 | $269K | Hold |
18,010
| – | – | 0.02% | 613 |
|
|
2024
Q4 | $342K | Buy |
+18,010
| New | +$381K | 0.02% | 520 |
|
|
2023
Q4 | – | Sell |
-10,150
| Closed | -$347K | – | 812 |
|
|
2023
Q3 | $347K | Hold |
10,150
| – | – | 0.03% | 501 |
|
|
2023
Q2 | $367K | Hold |
10,150
| – | – | 0.03% | 448 |
|
|
2023
Q1 | $399K | Sell |
10,150
-8,200
| -45% | -$301K | 0.03% | 435 |
|
|
2022
Q4 | $584K | Buy |
18,350
+9,540
| +108% | +$288K | 0.05% | 323 |
|
|
2022
Q3 | $250K | Hold |
8,810
| – | – | 0.02% | 582 |
|
|
2022
Q2 | $315K | Hold |
8,810
| – | – | 0.03% | 502 |
|
|
2022
Q1 | $434K | Hold |
8,810
| – | – | 0.03% | 451 |
|
|
2021
Q4 | $492K | Hold |
8,810
| – | – | 0.04% | 428 |
|
|
2021
Q3 | $511K | Hold |
8,810
| – | – | 0.04% | 394 |
|
|
2021
Q2 | $557K | Hold |
8,810
| – | – | 0.05% | 361 |
|
|
2021
Q1 | $562K | Hold |
8,810
| – | – | 0.05% | 333 |
|
|
2020
Q4 | $461K | Sell |
8,810
-6,000
| -41% | -$296K | 0.04% | 363 |
|
|
2020
Q3 | $648K | Buy |
+14,810
| New | +$655K | 0.07% | 222 |
|
|
2019
Q4 | – | Sell |
-9,670
| Closed | -$516K | – | 698 |
|
|
2019
Q3 | $516K | Hold |
9,670
| – | – | 0.08% | 257 |
|
|
2019
Q2 | $564K | Hold |
9,670
| – | – | 0.09% | 229 |
|
|
2019
Q1 | $480K | Buy |
+9,670
| New | +$426K | 0.08% | 256 |
|
|
2018
Q3 | – | Sell |
-4,770
| Closed | -$209K | – | 452 |
|
|
2018
Q2 | $209K | Hold |
4,770
| – | – | 0.04% | 396 |
|
|
2018
Q1 | $240K | Hold |
4,770
| – | – | 0.05% | 359 |
|
|
2017
Q4 | $314K | Hold |
4,770
| – | – | 0.07% | 294 |
|
|
2017
Q3 | $285K | Hold |
4,770
| – | – | 0.07% | 294 |
|
|
2017
Q2 | $309K | Hold |
4,770
| – | – | 0.08% | 280 |
|
|
2017
Q1 | $298K | Hold |
4,770
| – | – | 0.08% | 278 |
|
|
2016
Q4 | $275K | Buy |
+4,770
| New | +$282K | 0.08% | 279 |
|
Other funds holding XRAY
AI
SCA
CB
Everence Capital Management's XRAY Position: Q2 2026 in Review
Everence Capital Management sold out of Dentsply Sirona (XRAY) in Q2 2026, closing a stake of 18,382 shares — an estimated $213K sold.
Everence Capital Management first reported a position in XRAY in Q4 2016 and held it in 28 quarters. The position peaked at $648K in Q3 2020. 375 funds tracked by Wall St. Rank hold XRAY as of Q2 2026.
- Everence Capital Management reported no remaining Dentsply Sirona position as of Q2 2026 after selling out during the quarter.
- Everence Capital Management sold 18,382 Dentsply Sirona shares in Q2 2026, an estimated $213K.
- Everence Capital Management first reported a position in Dentsply Sirona in Q4 2016 and held it in 28 quarters.
- Everence Capital Management's Dentsply Sirona position peaked at $648K in Q3 2020.
- 375 funds tracked by Wall St. Rank held Dentsply Sirona as of Q2 2026.
Based on Everence Capital Management's 13F filing for Q2 2026, filed 4 Aug 2026.